Form 4 for BCPC BALCHEM CORP

Accepted 2026-02-13 00:00:00 ET · period of report 2026-02-11 · accession 0001140361-26-005520 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2026-02-13	2026-02-11	BCPC	Boned Frederic	SVP, GM, Human Nutri, Health	A - Grant	$0.00	+5,117	10.3K	+98%	$0
DM	2026-02-13	2026-02-11+	BCPC	Boned Frederic	SVP, GM, Human Nutri, Health	F - Tax	$178.50	-1,354	8,978	-13%	-$241.7K
D	2026-02-13	2026-02-11	BCPC	Boned Frederic	SVP, GM, Human Nutri, Health	A - Grant	$0.00	+10.5K	10.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-02-11	A	A	2,870	$0.00	8,085	D	—	—	(F1) Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
2	Common	Common Stock	2026-02-11	A	A	2,247	$0.00	10,332	D	—	—	(F2) Represents the vesting of performance stock units (includes 37 dividend equivalent shares) for the 2023-2025 performance period.
3	Common	Common Stock	2026-02-11	F	D	1,151	$178.68	9,181	D	—	—	(F3) 1,151 of the 2,247 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting.
4	Common	Common Stock	2026-02-12	F	D	203	$177.49	8,978	D	—	—	(F4) Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025).
5	Derivative	Stock Option	2026-02-11	A	A	10,500	$0.00	10,500	D	$178.68 · — to 2036-02-11	10,500 Common Stock	(F5) Options vest 20% Year 1, 40% Year 2, and 40% Year 3.